相关实验视频
Updated: Jun 29, 2025

08:40
Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
8.6K
甲基-CpG结合域蛋白2 (Mbd2) 通过调节上皮细胞到介质细胞的转变驱动乳腺癌的进展
Niaz Mahmood1,2, Ani Arakelian1, Moshe Szyf3
1Department of Medicine, McGill University, Montréal, QC, H4A3J1, Canada.
Experimental & molecular medicine
|March 31, 2024
概括
甲基-CpG结合域蛋白2 (Mbd2) 缺失减缓了小鼠乳腺癌的生长和转移. 丧失Mbd2会影响表皮细胞到介质酶的过渡和PI3K/AKT通路的激活,这表明Mbd2是治疗标.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 甲基-CpG结合域蛋白2 (Mbd2) 与各种癌症有关.
- 在体内乳腺癌进展中Mbd2的确切作用尚不清楚.
研究的目的:
- 调查Mbd2在乳腺瘤生长和转移中的因果作用.
- 阐明Mbd2影响乳腺癌进展的分子机制.
主要方法:
- 在MMTV-PyMT转基因小鼠中对Mbd2进行基因淘汰.
- 在野生型和Mbd2-缺乏的小鼠之间对乳腺瘤进展动力学的比较分析.
- 初级瘤的转录和蛋白质组分析.
主要成果:
- 删除mbd2显著阻碍了原发性瘤生长和肺转移.
- 丧失Mbd2会废除诸如N-cadherin和骨质链等关键的上皮细胞转移标记物.
- 缺乏mbd2会影响PI3K/AKT通路的激活,这对瘤细胞生长和存活至关重要.
结论:
- Mbd2在推动乳腺癌的进展和转移方面发挥着关键作用.
- 向Mbd2可能为乳腺癌提供一种新的表观遗传治疗策略.
- 进一步研究Mbd2介导的表观遗传调节对于开发向疗法是有必要的.
相关概念视频
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

